The aim of the MSc in Cancer Immunotherapy is through an understanding of the numerous ways in which cancers and the immune system interact, to learn how cancer immunotherapies are developed. The utilisation of the immune system in cancer therapy has been a long standing goal in the field. The course will provide a thorough understanding of immune effector mechanisms and of cancer biology and the personal skills the students will develop, through problem-based learning and self-directed learning.
Alternatively, consider taking our other MSc Cancer Immunotherapy routes:
Why choose this course?
The normal entry requirements for the programme are:
For fees and funding options, please visit website to find out more.
The University of Hertfordshire offer a range of tuition fee discounts and non-repayable scholarships to support our postgraduate students, visit website to find out more.
In cancer immunology a long-term goal has been the activation of immune effector mechanisms for therapy. You will acquire skills needed for careers in the exponentially growing cancer immunotherapy industries (Roche, Merck, Astra Zeneca and Small Medium Sized Enterprises). Graduates of the MSc Cancer Immunotherapy may go on to work in a broad range of fields including: medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing/science journalism, education, or patent law. Alternatively, you may also use the MSc Cancer Immunotherapy degree to underpin an application to study for a research degree such as MRes, MSc by Research, or a PhD in a related field.
Please visit website for module details.
We’ll help transform your ambitions into life-changing reality At Herts, we offer a huge variety of postgraduate courses with flexible study options t...